| Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma J El Cheikh, R Massoud, I Abudalle, B Haffar, R Mahfouz, ... Bone marrow transplantation 52 (7), 1074-1077, 2017 | 43 | 2017 |
| Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation R Massoud, R Assi, E Fares, B Haffar, M Charafeddine, N Kreidieh, ... Journal of Clinical Virology 95, 36-41, 2017 | 19 | 2017 |
| Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience F Daniel, L Hassoun, M Husni, A Sharara, A Soweid, K Barada, B Haffar, ... Current Research in Translational Medicine 67 (1), 16-19, 2019 | 12 | 2019 |
| Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant R Salem, R Massoud, B Haffar, R Mahfouz, A Bazarbachi, J El-Cheikh Bone Marrow Transplantation 52 (8), 1187-1190, 2017 | 6 | 2017 |
| Thiotepa 10 mg/kg treatment regimen is superior to thiotepa 5 mg/kg in TBF conditioning in patients undergoing allogeneic stem-cell transplantation J El-Cheikh, R Massoud, N Moukalled, B Haffar, H Assi, A Zahreddine, ... Clinical Lymphoma Myeloma and Leukemia 18 (5), 368-374, 2018 | 4 | 2018 |
| Bendamustine as a bridge to allogeneic transplant in relapsed/refractory Hodgkin lymphoma patients who failed salvage brentuximab vedotin postautologous peripheral blood stem … J El Cheikh, R Massoud, B Haffar, E Fares, R Mahfouz, T Jisr, ... Leukemia & Lymphoma 58 (11), 2745-2747, 2017 | 3 | 2017 |
| Consolidation with Bortezomib, Lenalidomide and dexamethasone upgrades the complete remission rate after autologous hematopoietic cell transplantation in patients with multiple … I Aboudalle, B Haffar, R Massoud, A Bazarbachi, J Elcheikh Blood 130, 1821, 2017 | 2 | 2017 |
| Management of biochemical relapse during lenalidomide maintenance therapy post ASCT in multiple myeloma: a descriptive observational study of a single institution R El Sayed, Y Haibe, N Moukalled, R Massoud, J Kort, C Matar, ... BONE MARROW TRANSPLANTATION 54, 505-505, 2019 | | 2019 |
| Impact of geographic distance from transplant center for patients undergoing Allogeneic Stem Cell transplantation: A retrospective, single study B Haffar, R Massoud, N Moukalled, E Akl, A Zahreddine, R Nehme, ... BONE MARROW TRANSPLANTATION 53, 501-503, 2018 | | 2018 |
| Predictors Of Early Engraftment In Autologous Peripheral Stem Cell Transplantation. A single center experience R Massoud, Z Otrock, B Haffar, R Mahfouz, A Zahreddine, N Kreidieh, ... BONE MARROW TRANSPLANTATION 53, 512-513, 2018 | | 2018 |
| Impact of intensity of conditioning regiment on lung function in Lymphoma and myeloma patients undergoing autologous peripheral stem cell transplantation R Massoud, M Matar, B Haffar, A Zahreddine, S Abou Arbid, A Bazarbachi, ... BONE MARROW TRANSPLANTATION 53, 338-339, 2018 | | 2018 |
| Thiotepa 10 mg/kg seems superior to Thiotepa 5 mg/kg in the TBF conditioning regimen in patients undergoing allogeneic stem cell transplantation J El-Cheikh, R Massoud, N Moukalled, B Haffar, A Zahreddine, ... BONE MARROW TRANSPLANTATION 53, 294-295, 2018 | | 2018 |
| Management of Biochemical Relapse during Lenalidomide Maintenance Therapy Post ASCT in Multiple Myeloma: A Descriptive Observational Study of a Single Institution R El Sayed, Y Haibe, N Moukalled, R Massoud, B Haffar, A Zahreddine, ... Clinical Lymphoma, Myeloma and Leukemia 18, S254, 2018 | | 2018 |
| Travelling Related Risks After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Referred from Countries with Destroyed Healthcare System to Transplant Center in … B Haffar, R Massoud, N Moukalled, A Zahreddine, R Nehme, ... Clinical Lymphoma, Myeloma and Leukemia 18, S311-S312, 2018 | | 2018 |
| Real Life Experience with Plerixafor and Granulocyte Colony-Stimulating Factor for Mobilization of Autologous Peripheral Stem Cell Transplantation Y Haibe, N Moukalled, B Haffar, R Massoud, R Salem, R El Sayed, ... Clinical Lymphoma, Myeloma and Leukemia 18, S311, 2018 | | 2018 |
| Prolonged Complete Remission Using CAPIZZI-Regimen in Adults with Relapsed B-Cell Precursor Acute Lymphocytic Leukemia with No Access to CAR-T Cells, Inotuzumab or Blinatumomab Y Haibe, R Salem, B Haffar, H El Darsa, C Salem, A Bazarbachi, ... Clinical Lymphoma, Myeloma and Leukemia 18, S189-S190, 2018 | | 2018 |
| The Efficacy and Safety of Busulfan Dose Intensity with Fludarabine Conditioning Regimen for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell … R Massoud, R Heller, N Moukalled, C Matar, B Haffar, A Bazarbachi, ... Clinical Lymphoma, Myeloma and Leukemia 18, S310-S311, 2018 | | 2018 |
| Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory … H El Darsa, R Massoud, B Haffar, A Zaherddine, A Bazarbachi, J Elcheikh Blood 130, 5469, 2017 | | 2017 |
| Safety and Efficacy of Thiotepa Based Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Single Center Experience J Elcheikh, R Massoud, N Moukalled, B Haffar, A Zaherddine, C Maya, ... Blood 130 (Supplement 1), 5473-5473, 2017 | | 2017 |
| SAFETY AND EFFICACY OF TBF CONDITIONING IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION. A RETROSPECTIVE SINGLE CENTER EXPERIENCE. R Massoud, N Moukalled, B Haffar, A Zahreddine, A Bazarbachi, ... HAEMATOLOGICA 102, 864-864, 2017 | | 2017 |
Radwan MassoudUniversitätsklinikum Hamburg-Eppendorf (UKE)Verified email at uke.de
